{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:19:36Z","timestamp":1787501976389,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.braindev.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:56:24Z","timestamp":1585875384000},"page":"546-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A case of GABRA5-related developmental and epileptic encephalopathy with response to a combination of antiepileptic drugs and a GABAering agent"],"prefix":"10.1016","volume":"42","author":[{"given":"Ponghatai","family":"Boonsimma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirorat","family":"Suwannachote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chureerat","family":"Phokaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chupong","family":"Ittiwut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanya","family":"Suphapeetiporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vorasuk","family":"Shotelersuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2020.03.005_b0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-444-63326-2.00003-X","article-title":"Mutant GABA(A) receptor subunits in genetic (idiopathic) epilepsy","volume":"213","author":"Hirose","year":"2014","journal-title":"Prog Brain Res."},{"key":"10.1016\/j.braindev.2020.03.005_b0010","article-title":"Deleterious rare variants reveal risk for loss of GABAA receptor function in patients with genetic epilepsy and in the general population","volume":"11","author":"Hernandez","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.braindev.2020.03.005_b0015","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1113\/jphysiol.2010.186999","article-title":"Mutations in GABAA receptor subunits associated with genetic epilepsies","volume":"588","author":"Macdonald","year":"2010","journal-title":"J Physiol."},{"key":"10.1016\/j.braindev.2020.03.005_b0020","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/brain\/awy171","article-title":"De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy","volume":"141","author":"Butler","year":"2018","journal-title":"Brain."},{"key":"10.1016\/j.braindev.2020.03.005_b0025","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/brain\/awz123","article-title":"Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies","volume":"142","author":"Hernandez","year":"2019","journal-title":"Brain."},{"key":"10.1016\/j.braindev.2020.03.005_b0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1474-4422(18)30215-1","article-title":"Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study","volume":"17","author":"May","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.braindev.2020.03.005_b0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pediatrneurol.2014.01.025","article-title":"Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy","volume":"51","author":"Klehm","year":"2014","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.braindev.2020.03.005_b0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"10.1016\/j.braindev.2020.03.005_b0045","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ajhg.2017.09.008","article-title":"High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies","volume":"101","author":"Hamdan","year":"2017","journal-title":"Am J Hum Genet."}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038776042030111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038776042030111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:49:02Z","timestamp":1759952942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S038776042030111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S038776042030111X"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2020.03.005","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of GABRA5-related developmental and epileptic encephalopathy with response to a combination of antiepileptic drugs and a GABAering agent","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}